BD GENERICS ApS: Financial statements 2013
CVR: 28707207
Source: annual report 2013, Danish Business Authority
01/07/2012 – 30/06/2013
BD GENERICS ApS (CVR 28707207) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 1,537,914 and a net result of DKK 1,155,585 compared with DKK 1,141,759 the year before. That is an increase of 0.8% compared with the year before. Equity in the 2013 report amounted to DKK 1,771,740. The solvency ratio was 68.6%.
- Gross Profit
- DKK 1,537,914
- Profit/Loss
- DKK 1,155,585
- Equity
- DKK 1,771,740
- Total Assets
- DKK 2,582,950
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 1.5 mio. | 1.2 mio. | 1.8 mio. | - |
| 2012 | - | 1.5 mio. | 1.1 mio. | 1.6 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
BD GENERICS ApS has published its annual report for 2012. Gross profit came to DKK 1,525,713, and the net result was DKK 1,141,759.
About BD GENERICS ApS
BD GENERICS ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2005. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Gerner Jacobsen. The company is owned by TGJ HOLDING ApS. The company has 1 employee (2009). In 2025, the company reported a gross profit of DKK -117,586 and a net result of DKK -64,678 compared with DKK -61,196 the year before. Equity in the 2025 report amounted to DKK 638,280.